Brief: Theradiag announces results of the ROC trial
08/12/2015 16:45
Dec 8 (Reuters) - Theradiag SA ALTHE.PA :
* Results of the ROC trial demonstrate the benefits of monitoring biotherapies
* Further validation of value added by Lisa Tracker tests for monitoring treatments in
rheumatoid arthritis patients with a loss of response
Source text for Eikon: ID:nBwbgftHna
Further company coverage: ALTHE.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))